
Globe Life Inc.
- Jurisdiction
United States - LEI
5493001JFHKQOPP6XA71 - ISIN
US37959E1029 (GL )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€153.35 31.1% undervalued - Financial strength (Piotroski F-Value)
-
4
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
6
/ 7
Profile
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. Read full profile
Fundamentals
- Net revenue
€5.02B - Gross margin
44.8% - EBIT
€645.24M - EBIT margin
12.9% - Net income
€908.82M - Net margin
18.1%
Statement period: - (published )
Estimates
Fiscal Year | Net revenue | Net income |
---|---|---|
|
| |
|
| |
|
|
Stock price
Dividends
- Last dividend amount
-
$0.27 - Ex date
-
- Payment date
-
- Dividend payout ratio
-
7.9%
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Congress transactions
Name | Transaction date | Value |
---|---|---|
Lisa McClain | August 13, 2025 | $1.00K–$15.00K |
Lisa McClain | August 13, 2025 | $1.00K–$15.00K |
Susan Collins | August 5, 2024 | $15.00K–$50.00K |
Earnings Calls
Investor transactions
Name | Shares | Value | Last change | Change type |
---|---|---|---|---|
George Soros |
|
|
|
Buy |
Ray Dalio |
|
|
|
Buy |
Peter Brown |
|
|
|
Sell |
Earnings Calls
Latest earnings call: April 23, 2024 (Q1 2024)